Charles Schwab’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-339,142
| Closed | -$13.4M | – | 3713 |
|
|
2024
Q1 | $13.4M | Buy |
339,142
+41,690
| +14% | +$1.65M | ﹤0.01% | 1830 |
|
|
2023
Q4 | $5.67M | Buy |
297,452
+63,196
| +27% | +$1.2M | ﹤0.01% | 2256 |
|
|
2023
Q3 | $2.68M | Buy |
234,256
+147,976
| +172% | +$1.69M | ﹤0.01% | 2511 |
|
|
2023
Q2 | $887K | Buy |
86,280
+19,014
| +28% | +$195K | ﹤0.01% | 2812 |
|
|
2023
Q1 | $519K | Buy |
67,266
+2,770
| +4% | +$21.4K | ﹤0.01% | 2934 |
|
|
2022
Q4 | $474K | Buy |
64,496
+24,673
| +62% | +$181K | ﹤0.01% | 3016 |
|
|
2022
Q3 | $287K | Hold |
39,823
| – | – | ﹤0.01% | 3116 |
|
|
2022
Q2 | $339K | Buy |
39,823
+7,406
| +23% | +$63K | ﹤0.01% | 3173 |
|
|
2022
Q1 | $291K | Buy |
32,417
+2,294
| +8% | +$20.6K | ﹤0.01% | 3221 |
|
|
2021
Q4 | $418K | Buy |
30,123
+5,500
| +22% | +$76.3K | ﹤0.01% | 3203 |
|
|
2021
Q3 | $263K | Sell |
24,623
-4,137
| -14% | -$44.2K | ﹤0.01% | 3289 |
|
|
2021
Q2 | $259K | Buy |
+28,760
| New | +$259K | ﹤0.01% | 3254 |
|